Yu Wu
Impact in
-
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
-
- Cancer-related Molecular Pathways
Papers in
-
- Medical Research and Treatments 4
- Traditional Chinese Medicine Studies 3
- Oncology 8
- Co-authors
- Yajuan J. Liu (7 shared papers)Wenjing Wang (3 shared papers)Zoe Miner (2 shared papers)Molly F Kulesz-Martin (2 shared papers)Robert W. Ricciotti (3 shared papers)Min Huang (5 shared papers)Jacqueline Whang‐Peng (1 shared paper)Chi‐Ying F. Huang (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Genes Chromosomes and Cancer (2 papers)Human Pathology (2 papers)Chinese Journal of Integrative Medicine (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yu Wu
45 papers receiving 720 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 89
- Oncology 143
- Pulmonary and Respiratory Medicine 162
- Complementary and alternative medicine 46
- Rheumatology 54
Countries citing papers authored by Yu Wu
This map shows the geographic impact of Yu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wu more than expected).
Fields of papers citing papers by Yu Wu
This network shows the impact of papers produced by Yu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wu. The network helps show where Yu Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 116 | |
| 2 | 2021 | 56 | |
| 3 | 2017 | 54 | |
| 4 | 2005 | 51 | |
| 5 | 1994 | 42 | |
| 6 | Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma. | 2000 | 39 |
| 7 | 2019 | 38 | |
| 8 | 2017 | 31 | |
| 9 | 2008 | 27 | |
| 10 | 1997 | 22 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 19 | |
| 13 | Managements of locally advanced unresectable thymic epithelial tumors. | 2004 | 18 |
| 14 | 2021 | 18 | |
| 15 | 2020 | 14 | |
| 16 | 1988 | 13 | |
| 17 | 2017 | 13 | |
| 18 | 2020 | 12 | |
| 19 | Surgical results of upper thoracic esophageal carcinoma. | 2004 | 11 |
| 20 | Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor. | 2007 | 11 |
About Yu Wu
Yu Wu is a scholar working on Complementary and alternative medicine, Oncology, Pulmonary and Respiratory Medicine, Surgery and Gastroenterology, having authored 51 papers that have together received 733 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (6 papers), Medical Research and Treatments (4 papers), Traditional Chinese Medicine Studies (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Bone Tumor Diagnosis and Treatments (2 papers), Gestational Trophoblastic Disease Studies (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Medical Image Segmentation Techniques (2 papers). The work is most often cited by research in Cancer Research (89 citations), Oncology (143 citations), Pulmonary and Respiratory Medicine (162 citations), Complementary and alternative medicine (46 citations) and Rheumatology (54 citations). Yu Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yajuan J. Liu, Wenjing Wang, Zoe Miner, Molly F Kulesz-Martin, Robert W. Ricciotti, Min Huang, Jacqueline Whang‐Peng, Chi‐Ying F. Huang, Tai-Shan Cheng and Cheng‐Yu Chen. Their work appears in journals such as Frontiers in Oncology, Genes Chromosomes and Cancer, Human Pathology, Chinese Journal of Integrative Medicine and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.